Publication: Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-kappa B Signaling Pathway and NLRP3 Inflammasome Activation
| cris.lastimport.scopus | 2026-02-25T16:02:09Z | |
| dc.creator | Huang, Chi-Han | |
| dc.creator | Wang, Shu-Chi | |
| dc.creator | Chen, I-Chen | |
| dc.creator | Chen, Yi-Ting | |
| dc.creator | Liu, Po-Len | |
| dc.creator | Fang, Shih-Hua | |
| dc.creator | Huang, Shu-Pin | |
| dc.creator | Yeh, Hsin-Chih | |
| dc.creator | Liu, Ching-Chih | |
| dc.creator | Lee, Po-Yen | |
| dc.creator | Li, Chia-Yang | |
| dc.date | 2021-06 | |
| dc.date.accessioned | 2021-11-08T06:24:04Z | |
| dc.date.accessioned | 2025-07-27T15:03:16Z | |
| dc.date.available | 2021-11-08T06:24:04Z | |
| dc.date.issued | 2021-11-08T06:24:04Z | |
| dc.description.abstract | Piplartine (or Piperlongumine) is a natural alkaloid isolated from Piper longum L., which has been proposed to exhibit various biological properties such as anti-inflammatory effects; however, the effect of piplartine on sepsis has not been examined. This study was performed to examine the anti-inflammatory activities of piplartine in vitro, ex vivo and in vivo using murine J774A.1 macrophage cell line, peritoneal macrophages, bone marrow-derived macrophages and an animal sepsis model. The results demonstrated that piplartine suppresses iNOS and COX-2 expression, reduces PGE(2), TNF-alpha and IL-6 production, decreases the phosphorylation of MAPKs and NF-kappa B and attenuates NF-kappa B activity by LPS-activated macrophages. Piplartine also inhibits IL-1 beta production and suppresses NLRP3 inflammasome activation by LPS/ATP- and LPS/nigericin-activated macrophages. Moreover, piplartine reduces the production of nitric oxide (NO) and TNF-alpha, IL-6 and IL-1 beta, decreases LPS-induced tissue damage, attenuates infiltration of inflammatory cells and enhances the survival rate. Collectively, these results demonstrate piplartine exhibits anti-inflammatory activities in LPS-induced inflammation and sepsis and suggest that piplartine might have benefits for sepsis treatment. | |
| dc.format.extent | 103 bytes | |
| dc.format.mimetype | text/html | |
| dc.identifier.doi | 10.3390/ph14060588 | |
| dc.identifier.issn | 1424-8247 | |
| dc.identifier.uri | https://ir.ntus.edu.tw/handle/987654321/64478 | |
| dc.language | en_US | |
| dc.publisher | BASEL, SWITZERLAND: MDPI | |
| dc.relation | PHARMACEUTICALS, 14(6) | |
| dc.subject | piplartine | |
| dc.subject | macrophage | |
| dc.subject | inflammation | |
| dc.subject | NLRP3 inflammasome | |
| dc.subject | sepsis | |
| dc.title | Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-kappa B Signaling Pathway and NLRP3 Inflammasome Activation | |
| dc.type | article | |
| dspace.entity.type | Publication |